Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, United States.
Semin Ophthalmol. 2021 May 19;36(4):258-263. doi: 10.1080/08820538.2021.1893352. Epub 2021 Mar 2.
Telemedicine in ophthalmology, and specifically in retinal diseases, has made significant advancements in recent years. The COVID-19 pandemic has launched telehealth into a new era by creating demand from patients and physicians alike, while breaking down previous insurance, reimbursement, access and educational barriers.
This paper reviews mulitple studies demonstrating the use of telemedicine in managing various retinal conditions before and during the COVID-19 pandemic.
Moving forward, promising new devices and models of care ensure that tele-retinal care will continue to expand and become a vital part of how we screen, diagnose and monitor retinal diseases.
近年来，眼科领域的远程医疗，特别是视网膜疾病领域的远程医疗取得了重大进展。COVID-19 大流行通过满足患者和医生的需求，打破了先前在保险、报销、准入和教育方面的障碍，将远程医疗推向了一个新时代。
本文回顾了多项研究，展示了在 COVID-19 大流行之前和期间使用远程医疗来管理各种视网膜疾病的情况。
展望未来，有前途的新设备和护理模式确保远程视网膜护理将继续扩大，并成为我们筛查、诊断和监测视网膜疾病的重要组成部分。
